Cargando…
Risk factors associated with Retinopathy of Prematurity development and progression
Several studies propose that Retinopathy of Prematurity (ROP) is a multifactorial disorder implicating many prenatal and postnatal factors. The objective of our study was to determine the incidence and the risk factors that influenced ROP development and progression. We retrospectively compiled data...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767907/ https://www.ncbi.nlm.nih.gov/pubmed/36539470 http://dx.doi.org/10.1038/s41598-022-26229-4 |
_version_ | 1784854056640970752 |
---|---|
author | de las Rivas Ramírez, Nieves Luque Aranda, Guillermo Rius Díaz, Francisca Pérez Frías, Francisco Javier Sánchez Tamayo, Tomás |
author_facet | de las Rivas Ramírez, Nieves Luque Aranda, Guillermo Rius Díaz, Francisca Pérez Frías, Francisco Javier Sánchez Tamayo, Tomás |
author_sort | de las Rivas Ramírez, Nieves |
collection | PubMed |
description | Several studies propose that Retinopathy of Prematurity (ROP) is a multifactorial disorder implicating many prenatal and postnatal factors. The objective of our study was to determine the incidence and the risk factors that influenced ROP development and progression. We retrospectively compiled data of preterms with birth weight (BW) ≤ 1.500 g and/or gestational age (GA) < 32 weeks, or BW between 1.501 and 2.000 g and/or GA ≥ 32 weeks with oxygen supply > 72 h or unstable clinical course screened for ROP in Regional University Hospital of Málaga from 2015 to 2018. 202 infants (44.7%) developed ROP and 66 exhibited progression (32.7% of ROP infants). In the univariate analysis, many risk factors were associated with ROP. In the subsequent multivariate analysis, GA, oxygen therapy and weight at 28 days of life, mechanical ventilation duration, non-invasive ventilation, surfactant administration and late-onset sepsis were independently associated with the development. However, oxygen therapy duration, late-onset sepsis and weight at 28 days were associated with the progression. The ROP development and progression risk factors were different. Our results are important to facilitate screening, early diagnosis and ROP treatment while reducing unneeded examinations. |
format | Online Article Text |
id | pubmed-9767907 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-97679072022-12-22 Risk factors associated with Retinopathy of Prematurity development and progression de las Rivas Ramírez, Nieves Luque Aranda, Guillermo Rius Díaz, Francisca Pérez Frías, Francisco Javier Sánchez Tamayo, Tomás Sci Rep Article Several studies propose that Retinopathy of Prematurity (ROP) is a multifactorial disorder implicating many prenatal and postnatal factors. The objective of our study was to determine the incidence and the risk factors that influenced ROP development and progression. We retrospectively compiled data of preterms with birth weight (BW) ≤ 1.500 g and/or gestational age (GA) < 32 weeks, or BW between 1.501 and 2.000 g and/or GA ≥ 32 weeks with oxygen supply > 72 h or unstable clinical course screened for ROP in Regional University Hospital of Málaga from 2015 to 2018. 202 infants (44.7%) developed ROP and 66 exhibited progression (32.7% of ROP infants). In the univariate analysis, many risk factors were associated with ROP. In the subsequent multivariate analysis, GA, oxygen therapy and weight at 28 days of life, mechanical ventilation duration, non-invasive ventilation, surfactant administration and late-onset sepsis were independently associated with the development. However, oxygen therapy duration, late-onset sepsis and weight at 28 days were associated with the progression. The ROP development and progression risk factors were different. Our results are important to facilitate screening, early diagnosis and ROP treatment while reducing unneeded examinations. Nature Publishing Group UK 2022-12-20 /pmc/articles/PMC9767907/ /pubmed/36539470 http://dx.doi.org/10.1038/s41598-022-26229-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article de las Rivas Ramírez, Nieves Luque Aranda, Guillermo Rius Díaz, Francisca Pérez Frías, Francisco Javier Sánchez Tamayo, Tomás Risk factors associated with Retinopathy of Prematurity development and progression |
title | Risk factors associated with Retinopathy of Prematurity development and progression |
title_full | Risk factors associated with Retinopathy of Prematurity development and progression |
title_fullStr | Risk factors associated with Retinopathy of Prematurity development and progression |
title_full_unstemmed | Risk factors associated with Retinopathy of Prematurity development and progression |
title_short | Risk factors associated with Retinopathy of Prematurity development and progression |
title_sort | risk factors associated with retinopathy of prematurity development and progression |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767907/ https://www.ncbi.nlm.nih.gov/pubmed/36539470 http://dx.doi.org/10.1038/s41598-022-26229-4 |
work_keys_str_mv | AT delasrivasramireznieves riskfactorsassociatedwithretinopathyofprematuritydevelopmentandprogression AT luquearandaguillermo riskfactorsassociatedwithretinopathyofprematuritydevelopmentandprogression AT riusdiazfrancisca riskfactorsassociatedwithretinopathyofprematuritydevelopmentandprogression AT perezfriasfranciscojavier riskfactorsassociatedwithretinopathyofprematuritydevelopmentandprogression AT sancheztamayotomas riskfactorsassociatedwithretinopathyofprematuritydevelopmentandprogression |